⁯
=

***Dear Editor,***

Gene expression is mediated by chromatin epigenetic changes, including DNA methylation, histone modifications, promoter-enhancer interactions, and non-coding RNA (microRNA and long non-coding RNA)-mediated regulation (Chen et al., 2017\[[@R5]\]). Approximately 50 % of all tumor suppressor genes are inactivated through epigenetic modifications, rather than by genetic mechanisms, in sporadic cancers (Meeran et al., 2010\[[@R12]\]; Su et al., 2018\[[@R16]\]). Accumulating evidence suggests that epigenetic modulators are important tools to improve the efficacy of disease prevention strategies (Ratovitski, 2017\[[@R14]\]; Carlos-Reyes et al., 2019\[[@R4]\]; Hassan et al., 2019\[[@R8]\]).

Sulforaphane (\[1-isothioyanato-4-(methyl-sulfinyl)butane\], SFN) is a naturally occurring, sulfur-containing isothiocyanate derivative that is found in the seeds and sprouts of cruciferous vegetables such as broccoli, cabbage, cauliflower, and kale (Vanduchova et al., 2019\[[@R19]\]). Because SFN induces the nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element pathway that induces the cellular defense against oxidative stress (Trio et al., 2016\[[@R18]\]), SFN has received increased attention because it acts as an antioxidant, antimicrobial, anti-inflammatory, and anticancer agent (Vanduchova et al., 2019\[[@R19]\]). Various mechanisms, including apoptosis activation, nuclear factor-κB pathway inhibition, and cell cycle arrest induction, have been proposed to explain the beneficial effects of SFN in preventing multiple types of cancer (Tortorella et al., 2015\[[@R17]\]). Indeed, the increasing attention of SFN as an epigenetic modulator continues to contribute to new developments in clinical trials.

This letter presents a summary of key recent studies investigating the function of SFN as an epigenetic modulator in several human diseases (Table 1[(Tab. 1)](#T1){ref-type="fig"}; References in Table 1: Abbas et al., 2016\[[@R1]\]; Ali Khan et al., 2015\[[@R2]\]; Cao et al., 2018\[[@R3]\]; Fisher et al., 2016\[[@R6]\]; Gao et al., 2018\[[@R7]\]; Lewinska et al., 2017\[[@R9]\]; Li et al., 2019\[[@R10]\]; Lubecka-Pietruszewska et al., 2015\[[@R11]\]; Okonkwo et al., 2018\[[@R13]\]; Royston et al., 2018\[[@R15]\]; Yang et al., 2015\[[@R20]\]; Yuan et al., 2018\[[@R21]\]; Zhao et al., 2018\[[@R22]\]; Zhou et al., 2019\[[@R23]\]). I believe that this letter will stimulate future research on the development of SFN as an epigenetic modulator for successful chemo-prevention and alternative therapeutic approaches.

Conflict of interest
====================

The author declares no conflict of interest.

![Recent updates on sulforaphane (SFN) as a dietary epigenetic modulator](EXCLI-19-131-t-001){#T1}
